Adventures in HousingI've Always Wondered ...My EconomyTrump's Second Term

Loading...

0:00
0% played
No matter the season, there's always a reason to support Marketplace. 💙 Give Now 🎁

Gregory Warner

Reporter, Marketplace

SHORT BIO

Gregory Warner is a senior reporter for Marketplace, covering the business and economics of health care for the entire Marketplace portfolio. He’s taken on questions as varied as how drugs get named, how ineffective procedures become popular, and how politicians fuel a costly medical arms race.

Warner started at Marketplace in November of 2009. Previously, he freelanced radio stories from conflict zones such as Afghanistan, Pakistan and DR Congo. Before becoming a radio reporter, he lived in New York working as an investigator of police brutality and a jazz pianist in a piano bar.

Warner’s favorite interviews are ones where he takes a journey with people. Recent examples include jogging with a homeless persons’ running club in Philadelphia, enduring ‘empathy training’ with call center reps in Ky., and undergoing fear-based alcoholism treatment in Moscow.

Warner holds a degree in English from Yale. In 2009, he was awarded Best News Feature from the Third Coast International Audio Festival for a Marketplace and Homelands Productions profile of a Congolese miner. He also has two Edward R. Murrow awards and awards from Associated Press, Sigma Delta Chi (from the Society for Professional Journalists), New York Festivals and PRNDI.

Warner was born in New York and currently resides in Philadelphia. In his free time, he enjoys biking, Werner Herzog films, and making up songs for his 8-month-old son.

Latest Stories (258)

Americans purchase more even as net worth shrinks

by Gregory Warner
Dec 9, 2011
From July to September, American families purchased more, even as their net worth shrank faster than it has at any time since the worst of the financial crisis.
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Do the ratings agencies need a downgrade?

by Gregory Warner
Dec 8, 2011
Europe and the U.S. are both exploring new options for judging the value of debt after increasing threats of downgrade from agencies like S&P and Moody's.
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

The danger of relying on ratings agencies

by Gregory Warner
Dec 8, 2011
As economic turmoil continues in Europe, leaders there -- and here in the U.S. -- are weary of the blind reliance on ratings agencies to value debt.
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

The end of Medicare open enrollment for the year

by Gregory Warner
Dec 7, 2011
Today is the last day to choose a Medicare plan -- the end of so-called open enrollment. What does that mean for insurance customers?
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

President Obama takes aim at rising inequality

by Gregory Warner
Dec 7, 2011
Yesterday, the president spoke about the loss of the American dream. But just how much is the middle class really shrinking?
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Payroll tax decision nears end of the year deadline

by Gregory Warner
Dec 6, 2011
Senate Democrats want another vote this week on extending a payroll tax cut for workers. But Republicans say they can't support the Democratic proposal.
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

President Obama pushes to get CFPB head approved

by Gregory Warner
Dec 5, 2011
this week, President Obama's expected to put the pressure on Congress to approve his nominee to head the Consumer Finance Protection Bureau. But Republicans vow to hold up any nominee until the bureau itself gets overhauled.
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

CFPB at a standstill until director is approved

by Gregory Warner
Dec 5, 2011
The Consumer Financial Protection Bureau can investigate complaints, but that's about it -- at least until a head of the bureau is approved by Congress.
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Lipitor makes way for generics

by Gregory Warner
Nov 29, 2011
Pfizer's blockbuster cholesterol drug loses patent protection December 1. It could have happened sooner.
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Lipitor at the end of its patent

by Gregory Warner
Nov 28, 2011
Pfizer's big seller, Lipitor, loses its patent this week. But the drug giant isn't ready to give up all those customers just yet.
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE